Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Return on Assets data on record, last reported at 0.37% in Q3 2025.

  • For Q3 2025, Return on Assets fell 25.0% year-over-year to 0.37%; the TTM value through Sep 2025 reached 0.37%, down 25.0%, while the annual FY2023 figure was 0.47%, 113.0% up from the prior year.
  • Return on Assets reached 0.37% in Q3 2025 per CYCN's latest filing, up from 0.39% in the prior quarter.
  • Across five years, Return on Assets topped out at 1.56% in Q3 2023 and bottomed at 1.5% in Q3 2022.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.39% recorded in 2025.
  • Peak YoY movement for Return on Assets: soared 306bps in 2023, then crashed -168bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.87% in 2021, then grew by 1bps to 0.86% in 2022, then skyrocketed by 160bps to 0.51% in 2023, then tumbled by -113bps to 0.07% in 2024, then plummeted by -442bps to 0.37% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.37% in Q3 2025, 0.39% in Q2 2025, and 0.21% in Q1 2025.